ArticleDevelopmental medicine and child neurology2026
Selective Control Assessment of the Lower Extremity for Infants and Toddlers (Mini-SCALE): Development and validation of a clinical assessment.
Article in Developmental medicine and child neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Precision rehabilitation for cerebral palsy will require robust measures of motor control development.Developmental medicine and child neurology · 2026Article
- Selective Control Assessment of the Lower Extremity for Infants and Toddlers (Mini-SCALE): Development and validation of a clinical assessment.Developmental medicine and child neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
aimTo investigate the validity of Selective Control Assessment of the Lower Extremity for Infants and Toddlers (Mini-SCALE), an adaptation of Selective Control Assessment of the Lower Extremity (SCALE), in young children aged from 3 months to less than 4 years.
methodMini-SCALE was modified from SCALE and reviewed by 16 experienced clinicians to establish content validity. For convergent validity, Mini-SCALE was compared to the Developmental Assessment of Young Children, Second Edition, Gross Motor subdomain (DAYC-2 GM) for 50 participants (aged 4-46 months, 29 males) with cerebral palsy (CP) (n = 20), at risk for CP (n = 9), and typically developing participants (n = 21) using a prospective cross-sectional design. For known-group validity, the scores of children with or at risk for CP were compared to typically developing children using the Welch's two-sample t-test.
resultsContent validity was strong with 96.6% (range = 75%-100%) expert agreement on 54 statements about content, administration, and grading. Convergent validity was strong between Mini-SCALE and the DAYC-2 GM (Spearman's rank correlation coefficient, r
interpretationMini-SCALE is a valid measure of selective motor control for young children with or at risk for CP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.